accessibility menu, dialog, popup

UserName
Viewing profile as user:

Organic sodium salts

Organic compound that contains one or more sodium ions bonded by ionic bonds. Salts are products of acid-base reactions.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (4)

special interests

  • (4)

Search Within Results
Keyword Search:
1 – 4 of 4 results
1

Medchemexpress LLC DNQX (FG 9041) | 2379-57-9 | C8H4N4O6 | 100 MG
SDP

DNQX (FG 9041) is a quinoxaline derivative that functions as a selective, potent competitive non-NMDA glutamate receptor antagonist. It exhibits IC50 values of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors, respectively. This compound is known to selectively depolarize thalamic reticular nucleus (TRN) neurons.

  • Selective, potent competitive non-NMDA glutamate receptor antagonist
  • Exhibits IC50s of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors
  • Selectively depolarizes thalamic reticular nucleus (TRN) neurons
  • Purity of 99.67%
  • Molecular weight of 252.14
  • Appears as a white to off-white solid

ENCOMPASS_PREFERRED
2

Medchemexpress LLC DNQX | 2379-57-9 | C8H4N4O6 | 50 MG
SDP

DNQX (FG 9041) is a quinoxaline derivative that acts as a selective, potent competitive non-NMDA glutamate receptor antagonist. It exhibits IC50 values of 0.5 μM for AMPA receptors, 2 μM for kainate receptors, and 40 μM for NMDA receptors.

  • Selective non-NMDA glutamate receptor antagonist
  • Potent competitive antagonist
  • IC50s: 0.5 μM (AMPA), 2 μM (kainate), 40 μM (NMDA)
  • High purity (99.67%)
  • Available as solid and solution
  • In vivo dissolution protocols provided
  • In vitro, depolarizes thalamic reticular nucleus (TRN) neurons
  • In vivo, diminishes phencyclidine (PCP) hsp70 induction

ENCOMPASS_PREFERRED
3

Medchemexpress LLC Dnqx (FG 9041) | 2379-57-9 | C8H4N4O6 | 10 MM 1 ML
SDP

DNQX (FG 9041) is a quinoxaline derivative that functions as a selective, potent competitive non-NMDA glutamate receptor antagonist, demonstrating IC50 values of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors, respectively.

  • Selectively depolarizes thalamic reticular nucleus (TRN) neurons in vitro.
  • Significantly diminishes phencyclidine (PCP) induced hsp70 in posterior cingulate and retrosplenial cortex in vivo.

ENCOMPASS_PREFERRED
4

Medchemexpress LLC DNQX (FG 9041) | 2379-57-9 | C8H4N4O6 | 200 MG
SDP

DNQX (FG 9041) is a quinoxaline derivative and a selective, potent competitive non-NMDA glutamate receptor antagonist. It is characterized by its activity against various glutamate receptors.

  • Selective, potent competitive non-NMDA glutamate receptor antagonist
  • Targets AMPA receptors with an IC50 of 0.5 μM
  • Targets kainate receptors with an IC50 of 2 μM
  • Targets NMDA receptors with an IC50 of 40 μM
  • Selectively depolarizes thalamic reticular nucleus (TRN) neurons in vitro
  • Diminishes phencyclidine (PCP) induced hsp70 induction in vivo

ENCOMPASS_PREFERRED